JUL 2014 ARTICLE LIST >>
PharmaTutor (July- 2014)
ISSN: 2347 - 7881
Received On: 05/05/2014; Accepted On: 11/05/2014; Published On: 01/07/2014
AUTHORS: Sagar Vishwanath Sonawane*
Dept. of Pharmaceutical Sciences and Technology,
Institute of Chemical Technology,
Matunga, Mumbai, Maharashtra, India.
*sssagarvs@gmail.com
ABSTRACT:
Brain is the highly protected organ of the body by the sanctuary known as blood brain barrier (BBB). BBB comprises of tight junctions formed by the closed fenestration network of astrocytes, pericytes microglial cells and endothelial cells. Thus it is very difficult for drug molecules to cross BBB. Thus various approaches are discussed to overcome this barrier. Disruption of BBB was conventional invasive approach. The permeability of BBB increases in various diseases. This increased permeability of BBB is made use for drug trafficking. With advances in nanotechnology, various nanocarrier systems including Polymeric nanoparticles, Micelle, Dendrimer, Liposomes, Solid lipid nanoparticles, Nanostuctured lipid carriers, nanogels, etc. emerged as potential delivery systems.
Administration of inhibitors of p-glycoprotein with drug is another approach. Making lipophilic prodrugs of active drug substances can also be done.
Recently PEGylation of nanoparticles can be done to improve its half life in the body, known as the stealth technology. Further various receptor mediated processes are made use of for transport of nanocarrier across BBB. In this method the nanocarrier is attached to the targeting ligand thus making it receptor specific. The newer concept of molecular Trojan horses is also discussed. Finally the advantages of intranasal drug delivery are emphasized.
How to cite this article: SV Sonawane; Brain as a Sancturian Site in Drug Delivery Approaches to Improve Bioavailability in Brain; PharmaTutor; 2014; 2(7); 63-82
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Shinde, R.; B. Jindal, A.; V. Devarajan, P. Microemulsions and Nanoemulsions for Targeted Drug Delivery to the Brain. Curr. Nanosci. 2011, 7, 119–133.
2. Huynh, G. H.; Deen, D. F.; Szoka, F. C. Barriers to Carrier Mediated Drug and Gene Delivery to Brain Tumors. 2006, 110, 236–259.
3. Bhaskar, S.; Tian, F.; Stoeger, T.; Kreyling, W.; de la Fuente, J. M.; Grazú, V.; Borm, P.; Estrada, G.; Ntziachristos, V.; Razansky, D. Multifunctional Nanocarriers for Diagnostics, Drug Delivery and Targeted Treatment Across Blood-Brain Barrier: Perspectives on Tracking and Neuroimaging. Part. Fibre Toxicol. 2010, 7, 3.
4. Brasnjevic, I.; Steinbusch, H. W. M.; Schmitz, C.; Martinez-Martinez, P. Delivery of Peptide and Protein Drugs over the Blood-Brain Barrier. Prog. Neurobiol. 2009, 87, 212–51
5. Chen, Y.; Liu, L. Modern Methods for Delivery of Drugs Across the Blood–brain Barrier. Adv. Drug Deliv. Rev. 2012, 64, 640–665.
6. Misra, A.; Ganesh, S.; Shahiwala, A.; Shah, S. P. Drug Delivery to the Central Nervous System: a Review. J. Pharm. Pharm. Sci. 2003, 6, 252–73.
7. Bhagwat, R. R, I.S. Vaidhya Novel Drug Delivery Systems: An Overview International Journal of Pharmaceutical Sciences and Research,2013, 4, 970–982.
8. Ningaraj, N. S. Drug delivery to brain tumours:challenges and progress Expert Opin. Drug Deliv. 2006, 499–509.
9. Prabha, K. S.; Muthu, P. A Review?: Nanoparticles As Specified Carriers In Targeted Brain Drug Delivery System.American journal of pharmaceutical sciences 2011, 1.
10. Reddy, A. R. N. Reddy et Al., solid lipid nanoparticles: an advanced drug delivery system ;international Journal of Pharmaceutical Sciences and Research,. 2013, 4, 161–171
11. Giulia bonacucina, marco cespi, monica misici-falzi, giovanni f. Palmieri, Journal Of Pharmaceutical Sciences, VOL. 98, NO. 1,2009
12. Jung Kwon, Ray Drumright,Daniel J. Siegwart,Krzysztof Matyjaszwski,Progress in Polymer Science,vol 33, Issue 4, April 2008.448-477.
13. Wong, H. L.; Wu, X. Y.; Bendayan, R. Nanotechnological Advances for the Delivery of CNS Therapeutics. Adv. Drug Deliv. Rev. 2012, 64, 686–700
14. Banks, W. a. Drug Delivery to the Brain in Alzheimer’s Disease: Consideration of the Blood-Brain Barrier. Adv. Drug Deliv. Rev. 2012, 64, 629–39
15. Pisal, D. S.; Kosloski, M. P.; Balu-iyer, S. V. Delivery of Therapeutic Proteins, Journal of Pharmaceuticall Sciences2010, 99, 2557–2575
16. Angela R. Jones Eric V. Shusta, Blood-Brain Barrier Transport of Therapeutics via eceptor-Mediation, NIH Public Access. 2009, 24, 1759–1771
.png)
